The maternal-fetal interface has unique immunological response towards the implanting placenta. It is generally accepted that a T-helper type-2 (Th-2) cytokine prevailing environment is important in pregnancy. The proportion of Th-2 cells in the peripheral blood and deciduas is significantly higher in pregnant women than in nonpregnant women in the first trimester.
Introduction
Placenta is genetically a fetal semiallograft in the maternal body, and mechanisms have evolved to suppress the maternal immune response in the uterine tissue during pregnancy (Trowsdale and Betz, 2006) . One of these mechanisms is change in the decidual leukocyte population (Luppi, 2003) . The altered population of immune cells at the maternal-fetal interface not only allows the mother to tolerate the fetus but also to interact with the trophoblasts, thereby creating an environment that is favorable for fetal development (Luppi, 2003) . Contrary to their abundance in the peripheral blood, T-cells represent a minor population of immune cells in early decidua (Loke et al., 1995) , partly due to apoptosis of the leukocytes. The trophoblast cells express Fas ligand (FasL), which induces apoptosis of the Fas-expressing leukocytes (Runic et al., 1996; Green and Ferguson, 2001) . Other proposed mechanisms for the causing T-cells a minority population in the deciduas include inhibition of T-helper cells proliferation by indoleamine 2,3-dioxygenase from antigen-presenting cells (Mellor et al., 2002) , ligation of the inhibitory programmed death ligand 1 on uterine T cells (Guleria et al., 2005) , and selective enrichment of decidual natural killer cell (Bulmer and Lash, 2005) .
Despite the reduction of T-cell population in the decidua, considerable amount of T-cells are present around the extravillous trophoblasts, decidual stroma, endometrial gland and decidual vessels (Vassiliadou and Bulmer, 1998; Michimata et al., 2002) . T-helper cells are classified into T-helper type 1 (Th-1) and Th-2 according to the cytokines they secrete (Mosmann et al., 1986) . It is generally thought that successful pregnancy is a Th-2 type cytokine predominant phenomenon.
The percentage of peripheral blood (Saito et al., 1999b) and decidual (Michimata et al., 2002) Th-2 cells is significantly higher in pregnant women than in nonpregnant women in the first trimester. The shift from the production of inflammatory Th-1 cytokines towards Th-2 type cytokines promotes immune protection of the trophoblasts (Dealtry et al., 2000; Michimata et al., 2002; Straszewski-Chavez et al., 2005) . Pregnancy loss is associated with increased Th-1/Th-2 cytokine ratio (Daher et al., 2004) . However, several Th-1 cytokines such as (Chaouat, 2007) , suggesting that the Th1/Th2 paradigm for pregnancy may be too simplistic.
Glycodelin-A (GdA) is an immunosuppressive glycoprotein abundantly expressed in the decidualized endometrium (Seppala et al., 2002; Seppala et al., 2007) . It induces apoptosis of lymphocytes (Lee et al., 2009) and monocytes (Tee et al., 2008) , skewing of T-cell response towards Th-2 phenotype (Mishan-Eisenberg et al., 2004) , and modulates the activities of natural killer cells (Lee et al., 2010) , B-cells (Yaniv et al., 2003) , and dendritic cells (Scholz et al., 2008) . Recently, GdA was demonstrated to suppress the cytolytic activity of CD8 + T-cell (Soni and Karande, 2010) .
The immunosuppressive activities of GdA are believed to be related to fetomaternal defense (Clark et al., 1996) . The serum and decidual concentration of GdA peaks around week 10 of pregnancy, consistent with a role in survival of the fetoplacental unit (Seppala et al., 2002) . Decreased maternal serum glycodelin is associated with early spontaneous abortion (Salim et al., 2007) and recurrent from the cells. RNA was reverse transcribed using the TaqMan reverse transcription reagent kit (Applied Biosystems, Foster City, CA) and multiscript reverse transcriptase. qPCR was performed using the TaqMan PCR core reagent kit (N8080228, ABI Biosystems). In brief, cDNA sample (1 µL) was mixed with 2x TaqMan universal PCR master mix, Fas or FasL target primers and probe (ABI Biosystems) and 18S internal control primers and probe (ABI Biosystems) in a 96-well reaction plate (ABI Biosystems). The reactions were performed in triplicates. PCR was preformed at 50 for 2 minutes and 95 o C for 10 minutes, followed by 40 cycles at 95 o C for 15 seconds, and 60 o C for 1 minute in an ABI 7500 system (ABI Biosystems). The Ct values of the Fas and FasL experiments was <35 and that of 18S was <20, respectively. The relative quantification value (RQ) was calculated by 2 -ΔΔCT method (Schmittgen and Livak, 2008) . The data was present as relative expression = (RQ of glycodelin-treated cells -RQ of negative control)/(RQ of control cells -RQ of negative control).
The levels of soluble Fas (sFas) and FasL (sFasL) in the culture supernatant of the treated cells were measured by ELISA according to the manufacturer's protocol (Bender Medsystem®, Burlingame, CA). Briefly, the microwell coated with sFas or FasL monoclonal antibodies were washed twice with 300 µL of wash buffer. One hundred microlitres of culture medium or standard was then added to the well, washed and incubated with biotin-conjugated detector antibodies for 2 hours at 37 o C. The unbound material was washed away and streptavidin-HRP (100 µL per well) was added. Color development was performed using 100 μL of 3.3',5. chromogen. The reaction was stopped by the addition of 2 M sulphuric acid (1000 μL/well) and the absorbance was measured immediately at 450 nm with λ correction at 595 nm in an ELISA plate reader (Infinite F200, Tecan, Männedorf, Switzerland).
Caspase-3, -8 and -9 activity assays
Cells (1x10 6 ) were treated with different concentrations (0.01-1 μg/mL) of GdA in 500 μL of culture medium for 48 hours before the caspases activity assay. Caspase activities were determined with the use of synthetic substrates of caspase-3 (Z-DEVD-R110, Invitrogen), caspase-8 (IETD-pNA, Invitrogen) and caspase-9 (Ac-LEHD-pNA, Millipore). Cells were washed with PBS and lysed with 50 μL of cell lysis buffer provided by the assay kit at 4 o C for 1 hour. The cell lysate (50 μL) was then mixed with different caspase substrates in 50 μL of reaction buffer and incubated in dark according to the manufacturer's protocols. The fluorescence intensity or absorbance was measured immediately after incubation. Caspase activities were expressed as relative activity (%) = (Absorbance of glycodelin-treated cells -Absorbance of blank)/(Absorbance of control cells -Absorbance of blank) × 100%.
Western blot analysis of MAPK/ERK activation
The action of GdA on the MAPK/ERK activation in T-helper cells (1x10 6 ) was determined by western blot analyses after treatment of GdA (1 μg/mL) for 6 hours followed by the phytohaemagglutinin (5 μg/mL) stimulation for 30 minutes. Cells were lysed with CytoBluster TM protein extraction reagent (Novagen®, Darmstadt, Germany) 
GdA binding assay
GdA was labeled with Alexa Flour®488 according to the manufacturer's protocol (Invitrogen).
Cells (5x10 5 ) were incubated with the labeled GdA (1 μg/mL) for 2 hours. Unbound GdA was removed by washing with PBS twice. The samples were then re-suspended in 500 µL of PBS and analyzed by flow cytometry. The fluorescence signals were measured using 525 nm band pass filter and the data were analyzed by WinMDI 2.8 software.
Data Analysis
All values were expressed as mean ± SEM. For all experiments, the non-parametric ANOVA on Rank test for comparisons was used to identify differences between groups. If the data were Rafael, CA) with a P-value less than 0.05 was considered as significant.
Results

GdA increased the proportion of Th-2 cells in the T-helper cell population
T-helper cells (CD3 + CD4 + ) were isolated by negative immuno-magnetic separation and treated with different concentrations of GdA. The non-viable cells were removed by gating with forward scatter/side-scatter. In the viable population, the treatment significantly increased the proportion of CD4 + CD294 + cells (Th-2 cells) after 48 hours (Figure 1 ). Treatment with 1 μg/mL of GdA increased the percentage of Th-2 cells from 1.05±0.07% (Control) to 1.34±0.08% (P<0.05). As a result, the ratio of viable CD4 + CD294 -(Th-1) cells to CD4 + CD294 + (Th-2) cells decreased from 94.33 to 72.56 (P<0.05). The change in Th1/Th2 ratio could be due to a decrease in Th-1 cells or an increase in Th-2 cells. Therefore, we studied the action of GdA on the two isolated sub-populations.
GdA induced cell death of the Th-1 cells but not the Th-2 cells
GdA at concentrations ≥0.1 μg/mL significantly decreased (P<0.05) the viability of the isolated T-helper cells as demonstrated by the XTT assay (Table 1) GdA had no effect on caspase-3, -8 and -9 expression in the Th-2 cells.
GdA suppresses ERK activation in isolated T-helper cells and Th-1 cells
The expression and activation by PHA of ERK, p38 and JNK were determined by Western blot analysis. GdA dose-dependently reduced the phosphorylated-ERK level, but not that of phosphorylated-JNK nor phosphorylated-p38 in the T-helper cells ( Figure 3A ). GdA at a concentration of 1 μg/mL significantly reduced the levels of the 42 kDa and the 44 kDa phosphorylated-ERK to 0.48±0.11 and 0.61±0.09 (P<0.05) respectively, as compared to the control without treatment. GdA treatment did not affect the expression or phosphorylation of p38 or JNK.
GdA suppressed (P<0.05) the phosphorylated-ERK level in the PHA-stimulated Th-1 cells but not the Th-2 cells ( Figure 3B ). Treatment with 1 µg/mL of GdA decreased (P<0.05) the expression of phosphorylated-p42 and p44 ERKs in the Th-1 cells to 0.58±0.09 and 0.57±0.10, respectively, but had no effect on the non-phosphorylated ERK.
GdA had similar binding on Th-1 and Th-2 cells
The binding of fluorescent labeled GdA on Th-1 and Th-2 cells was determined by flow cytometry (Supporting information Figure S3 ). The percentage of Th-1 cells with bound GdA (91.17±0.90%) was not significantly different from that of Th-2 cells (93.77±0.84%), indicating that the binding of GdA to these cells was similar. 
Discussion
The maintenance of pregnancy requires a Th-2 cytokine dominant environment (Dealtry et al., 2000; Michimata et al., 2002) . Dysregulation of Th-1 and Th-2 cells is associated with implantation failure and recurrent pregnancy loss (Daher et al., 2004) . The ratio of Th-1/Th-2 cells decrease drastically in the peripheral blood and early decidua of pregnant women when compared with the nonpregnant one (Saito et al., 1999a; Saito et al., 1999b; Michimata et al., 2002) . Such a change has been proposed to be resulted from selective modulation of differentiation, chemoattraction, and proliferation of Th-2 cells and death of Th-1 cells. GdA stimulates the Th-2 type cytokine shift in T-cells (Mishan-Eisenberg et al., 2004) . However, the specific mechanisms of action are still unclear.
This study provides evidence for a novel mechanism of GdA in shifting the Th-1/Th-2 balance, i.e. differential actions on Th-1 and Th-2 cells in terms of selective induction of cell death, concomitant with increased expression of Fas in the Th-1 cells.
Cytotoxic action of GdA on T-cells has been reported (Sundarraj et al., 2008; Lee et al., 2009) .
In this study, both the T-helper and enriched Th-1 cells responded similarly to GdA-mediated cell death. It is because the major population in the peripheral blood T-helper cells was the Th-1 cells, and Th-2 cells only constitute a minor proportion ranging from 0.4-6.5% (Nagata et al., 1999) . The cytotoxic action of GdA on Th-1 cells is glycan-dependent, consistent with the reported contribution of the glycosylation of GdA to its binding to (Ish-Shalom et al., 2006) (Lee et al., 2009 ). On the other hand, GdA has no effect on the isolated Th-2 population.
The percentage of peripheral blood Th-2 cells is significantly higher in pregnant women than in nonpregnant women in the first trimester of pregnancy (Saito et al., 1999a) . The dosage (0.1-1 g/ml) of GdA exerting its biological activities in this study is within the concentration range of GdA (0.2-1.2 g/ml) in the peripheral blood of women in their first trimester of pregnancy (Seppala et al., 2002) , suggesting that the observations could be physiologically relevant. Due to the high abundance of GdA in the first-trimester decidual tissue, it is possible that GdA may possess similar actions on decidual T-cells. However, experimental evidence on this possibility is still lacking.
GdA increased apoptotic and necrotic cell death of the Th-1 subpopulation. Previous studies had reported differential effects of apoptotic and necrotic cells in modulating the activities of other immune cells. For example, the presence of apoptotic, but not the necrotic T-cells, up-regulates IL-10 production from macrophages (Chung et al., 2007) . The development of dendritic cells is also affected by apoptotic T-cells (Newton et al., 2003) . Therefore, the changes in apoptotic and necrotic T-cell population induced by GdA may further modulate the immune response of pregnant women.
The results of this study showed that GdA-induced cell death in both T-helper cells and Th-1 cells are associated with the increase in caspase-3, -8, -9 activities. This suggests that both 343 mitochondrial-dependent pathway as indicated by influx of mitochondrial membrane calcium ion and involvement of caspase-9 and Bcl-2 activities (Sundarraj et al., 2008) . There are no reports on the involvement of mitochondrion-independent pathway in GdA-mediated cell death of lymphocytes, whereas both recombinant glycodelin and native GdA have been reported to induce cell death of monocytes via caspase-8 pathway (Tee et al., 2008) .
A novel observation in this study is the differential induction of GdA on Fas expression in T-cells; it was enhanced by GdA in the Th-1, but not the Th-2 cells. Fas/FasL pathway regulates clonal deletion of T-cells at the fetomaternal interface (Coumans et al., 1999; Jerzak and Bischof, 2002) , as well as in some other immunologically privileged sites, such as the anterior chamber of the eye and the testis (Green and Ferguson, 2001) . The trophoblasts express FasL (Runic et al., 1996) , while the T-helper cells produce both Fas and FasL (Ramsdell et al., 1994) . Binding of FasL to Fas receptor induces trimerization of the Fas receptor, which activates the Fas-associated death domain and the caspase cascade leading to apoptosis. Most importantly, the Th-1 cells express more Fas receptors than the Th-2 cells do, and they are more susceptible to Fas/FasL-induced cell death (Roberts et al., 2003) . Thus, the up-regulation by GdA of Fas receptor in the Th-1 cells may further increase vulnerability of these cells to death-induction by the FasL derived from the trophoblasts or lymphocytes.
In this study, we further demonstrate the suppressive effect of GdA on ERK activation in the (Dong et al., 2002) . It has been correlated with Th-1 response (Borovsky et al., 2002) , and regulation of the expression of Th-1 cytokines including IL-1 (Wang et al., 2004) and IFN-γ (Mainiero et al., 1998) in different cell types. The ERK activation in T-cells also inhibited the cells to Fas-mediated apoptosis (Holmstrom et al., 2000) . Therefore, apart from inducing Fas expression, GdA treatment may sensitize Th-1 cells to Fas receptor-mediated apoptosis by suppressing ERK activation in the cells, as has been shown in primary peripheral T-cells after inhibition of ERK signaling (Holmstrom et al., 2000) . It is of interest that GdA also suppresses ERK activation in spermatozoa (Yeung et al., 2009 ) and trophoblast cells (Lam KKW and Chiu PCN, unpublished data), suggesting that ERK may have a central role in GdA signaling in different biological systems.
Consistently, the lack of cytotoxic activity of GdA on Th-2 cells is associated with absence of ERK suppression in these cells.
The observation of similar binding of GdA onto Th-1 and Th-2 cells suggests that GdA binding alone does not contribute to the differential response of Th-1 and Th-2 cells to GdA treatment.
However, the observation does not exclude the possible presence of different GdA receptors with the same affinity in the two cell types. CD45 has been proposed as a possible GdA receptor in T-cells (Rachmilewitz et al., 2003) . Differential expression of the CD45RC isoform in CD4 + T-cells sub-populations is associated with differences in cytokine production upon stimulation; the CD45RC high sub-population produces mainly type-1 cytokines including IL-2, while the CD45RC low sub-population produces IL-17, IL-10 and Th-2 cytokines (Ordonez et al., 2009) 
Figure 3 Effect of GdA on ERK activation in T-helper, Th-1 and Th-2 cells. (A) T-helper, (B)
Th-1 and Th-2 cells (1x10 6 ) were incubated with 1 μg/mL of GdA for 6 hours followed by PHA 553  554  555  556  557  558  559  560  561  562  563  564  565  566  567  568  569  570  571  572  573  574  575  576  577  578  579  580  581  582  583  584  585  586  587  588  589  590  591  592  593  594 595 596 ERK (p42) 0.89 ± 0.12 1.02 ± 0.02 1.00 ± 0.07 pERK (p42) 0.80 ± 0.22 0.60 ± 0.09 * 0.48 ± 0.11 * ERK (p44) 0.96 ± 0.03 0.99 ± 0.05 0.97 ± 0.03 pERK (p44) 0.89 ± 0.11 0.72 ± 0.03 * 0.61 ± 0.09 * p38 1.09 ± 0.02 1.11 ± 0.10 1.09 ± 0.09 pp38
1.03 ± 0.06 0.91 ± 0.07 0.92 ± 0.09 JNK (p46) 1.01 ± 0.04 0.93 ± 0.04 0.94 ± 0.08 pJNK (p46) Not detected JNK (p54) 1.03 ± 0.04 1.14 ± 0.08 1.09 ± 0.18 pJNK (p54kD) 1.00 ± 0.03 1.01 ± 0.03 1.07 ± 0.06
Densitometry (Relative quantification)
GdA (1 μg/mL) ERK (p42) Th-1 1.01 ± 0.20 Th-2 1.05 ± 0.07 pERK (p42) Th-1 0.58 ± 0.09 * Th-2 0.88 ± 0.13 ERK (p44) Th-1 1.05 ± 0.14 Th-2 1.11 ± 0.10 pERK (p44) Th-1 0.57 ± 0.10 * Th-2 0.83 ± 0.17 
